🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $EXPN.L and executed a SELL strategy, securing a +27.05% net profit.

UPGRADE TO SEE LIVE SIGNALS

$SPRY

ARS Pharmaceuticals Inc

United StatesUNITED STATES
FREE PREVIEW
🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Pharmaceuticals Major
AVG HISTORICAL GAP0.51%
MAX GAP RECORD12.99%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.0%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL